Roseola epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m (Bot: Removing from Primary care) |
||
| (5 intermediate revisions by 4 users not shown) | |||
| Line 2: | Line 2: | ||
{{Roseola}} | {{Roseola}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}}{{DAMI}} | ||
==Overview== | ==Overview== | ||
Roseola is an illness of young children, with a peak [[prevalence]] between 7 and 13 months. Ninety percent of cases occur in children younger than two years. Roseola occurs equally in boys and girls. It occurs throughout the year, although outbreaks may occur in groups according to season . | There is no accurate data for the [[prevalence]] or [[incidence]] of roseola. This is because the disease is a self limiting disease and it is under reported in most cases. Roseola is an illness of young children, with a peak [[prevalence]] between 7 and 13 months. Ninety percent of cases occur in children younger than two years. Roseola occurs equally in boys and girls. It occurs throughout the year, although outbreaks may occur in groups according to season . | ||
==Epidemiology and demographics== | ==Epidemiology and demographics== | ||
| Line 11: | Line 11: | ||
===Prevalence=== | ===Prevalence=== | ||
*There is no accurate data for the [[prevalence]] or [[incidence]] of roseola. | *There is no accurate data for the [[prevalence]] or [[incidence]] of roseola. | ||
*More than 90% of adult populations in developed countries are [[seropositive]] for | *More than 90% of adult populations in developed countries are [[seropositive]] for HHV 6. | ||
===Age=== | ===Age=== | ||
| Line 17: | Line 17: | ||
===Gender=== | ===Gender=== | ||
* | *Males and females are affected equally by roseola.<ref name="pmid8265302">{{cite journal| author=Asano Y, Yoshikawa T, Suga S, Kobayashi I, Nakashima T, Yazaki T et al.| title=Clinical features of infants with primary human herpesvirus 6 infection (exanthem subitum, roseola infantum). | journal=Pediatrics | year= 1994 | volume= 93 | issue= 1 | pages= 104-8 | pmid=8265302 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8265302 }} </ref> | ||
===Race=== | ===Race=== | ||
| Line 27: | Line 27: | ||
===Developing countries=== | ===Developing countries=== | ||
*There is a strong association of | *There is a strong association of HHV 6A in Zambian children when compared to rest of the world. | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Emergency mdicine]] | |||
[[Category:Disease]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | |||
[[Category:Neurology]] | |||
[[Category:Pediatrics]] | |||
[[Category:Dermatology]] | |||
Latest revision as of 00:03, 30 July 2020
|
Roseola Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Roseola epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Roseola epidemiology and demographics |
|
Risk calculators and risk factors for Roseola epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Omodamola Aje B.Sc, M.D. [2]
Overview
There is no accurate data for the prevalence or incidence of roseola. This is because the disease is a self limiting disease and it is under reported in most cases. Roseola is an illness of young children, with a peak prevalence between 7 and 13 months. Ninety percent of cases occur in children younger than two years. Roseola occurs equally in boys and girls. It occurs throughout the year, although outbreaks may occur in groups according to season .
Epidemiology and demographics
Prevalence
- There is no accurate data for the prevalence or incidence of roseola.
- More than 90% of adult populations in developed countries are seropositive for HHV 6.
Age
Roseola commonly affects young children between the ages of 7 and 13 months.[1]
Gender
- Males and females are affected equally by roseola.[2]
Race
- There is no racial predilection for roseola.
Developed countries
- HHV6 infection is nearly universal accounting for 10-45% of febrile illness in infants.
Developing countries
- There is a strong association of HHV 6A in Zambian children when compared to rest of the world.
References
- ↑ JURETIC M (1963). "Exanthema subitum a review of 243 cases". Helv Paediatr Acta. 18: 80–95. PMID 13958107.
- ↑ Asano Y, Yoshikawa T, Suga S, Kobayashi I, Nakashima T, Yazaki T; et al. (1994). "Clinical features of infants with primary human herpesvirus 6 infection (exanthem subitum, roseola infantum)". Pediatrics. 93 (1): 104–8. PMID 8265302.